Trials / Unknown
UnknownNCT05660057
Testing of a New Computer Screen for Patients With Persistent Concussion Symptoms (PCS).
Evaluation of a New Computer Screen for Patients With Persisting Concussion Symptoms Including Computer Screen Intolerance.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine whether a newly designed monitor for computers is better tolerated by concussed patients than the standard computer monitor. The information gathered from this study will contribute to the understanding of the persisting concussion symptoms including computer screen intolerance and photosensitivity, with the aim of helping those with concussions.
Detailed description
The study will involve completing a reading task on the standard computer monitor and the newly designed computer monitor. First, participants will be asked to rate their pre-test symptoms using a SCAT-III symptom checklist. Then they will read a short story and watch moving images on one of the devices (standard computer monitor or the newly designed computer monitor) for 30 minutes or until persisting concussion symptoms of moderate severity arise. Then, they will be asked to rate their post-test clinical symptoms using a SCAT-III symptom checklist. On a second visit, 7 to 10 days later, they will do the same activity on the other device. Each visit will take 60 minutes. The study will involve 100 patients with a history of concussion and computer screen intolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | New computer monitor | The device to be studied is a newly designed computer monitor and will be compared with the standard computer monitor. |
Timeline
- Start date
- 2022-11-07
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2022-12-21
- Last updated
- 2023-03-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05660057. Inclusion in this directory is not an endorsement.